ReviewInfectious disease clinics of North America2017
Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations.
Review in Infectious disease clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis.BMJ open · 2023Pooled it
- Comorbidity Burden and Radiological Features Associated withPathogens (Basel, Switzerland) · 2026Article
- Article
- Host, Pathogen, and Pulmonary Anatomy in Pneumonia: An Integrated Imaging and Clinical Perspective.Diagnostics (Basel, Switzerland) · 2026Review
- Monotherapy versus combination therapy in severe Legionella pneumonia: a multicenter retrospective observational study.Critical care (London, England) · 2026Observational
- Doxycycline forThe Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2026Review
- Article
- Metagenomic next-generation sequencing reveals airway microbial dysbiosis and functional alterations inFrontiers in cellular and infection microbiology · 2026Article
- Review
- Sepsis related Brugada syndrome in community acquired pneumonia due to Legionella pneumophila: a case report.BMC pulmonary medicine · 2025Article
- Predictive Factors for Invasive Mechanical Ventilation in Community-acquired Pneumonia.Internal medicine (Tokyo, Japan) · 2025Article
- Bacterial translocation and gut microbiome imbalance in an experimental infection model of legionellosis in guinea pigs.BMC microbiology · 2025Article
- Integrated Molecular Diagnostics UnmaskInfection and drug resistance · 2025Article
- SevereFrontiers in oncology · 2025Article
- The hidden dancers in water: the symbiotic mystery ofFrontiers in microbiology · 2025Review
- A case-control study onFrontiers in medicine · 2025Article
- Severe Legionnaires' disease refractory to azithromycin: Are quinolones superior to macrolides?IDCases · 2025Article
- Lymphadenitis caused byFrontiers in medicine · 2025Article
- Omadacycline for the Treatment of SevereInternational medical case reports journal · 2025Article
- Antibiotic susceptibility situation of environmentalJournal of water and health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe legionella pneumonia poses a diagnostic challenge and requires early intervention. Legionnaire's disease can have several presenting signs, symptoms, and laboratory abnormalities that suggest that Legionella pneumophila is the pathogen, but none of these are sufficient to distinguish L pneumophila pneumonia from other respiratory pathogens. L pneumophila is primarily an intracellular pathogen and needs treatment with antibiotics that efficiently enter the intracellular space.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.